Advertisement

Ageism Leaves Older Patients Out Of Important Clinical Trials For COVID-19, Says Harvard Researcher04:32
Download

Play
This article is more than 1 year old.

The race to find new treatments for the coronavirus is heating up throughout the country, including here in Massachusetts, as vaccines and treatments progress into human trials.

But a recent review led by Harvard Medical School researchers shows elderly people are routinely excluded from COVID-19 treatment trials, even as 80% of COVID-related deaths occur in people over age 65.

Dr. Sharon Inouye, a geriatrician with Harvard Medical School and Hebrew SeniorLife who led that study, joined WBUR's Morning Edition to talk about how ageism is affecting COVID-19 treatments.

This article was originally published on June 25, 2020.

Related:

Bob Oakes Twitter Senior Correspondent
Bob Oakes has been WBUR's Morning Edition anchor since 1992.

More…

Khari Thompson Twitter Field Producer, Morning Edition
Khari Thompson was the field producer for WBUR's Morning Edition.

More…

Advertisement

Advertisement